Kinloch Capital LLC Buys Shares of 4,497 Merck KGaA $MKGAF

Kinloch Capital LLC purchased a new position in Merck KGaA (OTCMKTS:MKGAF) during the second quarter, Holdings Channel reports. The institutional investor purchased 4,497 shares of the company’s stock, valued at approximately $578,000.

A number of other institutional investors also recently modified their holdings of the company. Frazier Financial Advisors LLC acquired a new stake in shares of Merck KGaA during the second quarter worth $25,000. Rakuten Securities Inc. acquired a new position in Merck KGaA in the second quarter valued at $27,000. Solstein Capital LLC bought a new stake in Merck KGaA during the second quarter valued at $33,000. Burk Holdings LLC bought a new stake in Merck KGaA during the second quarter valued at $39,000. Finally, Bard Associates Inc. acquired a new stake in Merck KGaA during the 2nd quarter worth about $60,000. 0.10% of the stock is owned by institutional investors.

Merck KGaA Stock Performance

MKGAF stock opened at $163.45 on Tuesday. The stock has a 50-day moving average price of $162.78 and a 200-day moving average price of $148.59. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a market cap of $21.12 billion, a PE ratio of 24.95 and a beta of 0.96.

Merck KGaA Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.